Eledon Pharmaceuticals
ELDN | NASDAQ
$1.97
-$0.15 (-6.86%)
At close: Nov 16, 2026, 4:00 PM ET
$2.01
+$0.04 (+2.03%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-6.86%
(1D)No price chart data available for 1D timeframe.
Rating
33.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #699/1021 (Top 68%)
Key Statistics
Market Data
Market Cap $226M
1D Range
1.92 2.22
52W Range
1.39 4.21
Valuation (TTM)
PE -2.49
PB 3.24
EV/EBITDA -2.33
Valuation (NTM)
Forward PE N/A
Forward PEG -0.07
Price Target $5.00
Cash Flow
FCF Yield -34.7%
SBC Adj. FCF Yield -39.0%
SBC Impact -12.4%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 95.8% |
28.8%
FCF 3Y | 5Y -33.6% |
-25.4%
Returns
ROA -79.7%
ROE -105.2%
ROIC -91.5%
Financial Health
Net Cash
$69.67M
Current Ratio 6.30
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), ...
Sector Healthcare
Industry Biotechnology
Employees 33
IPO Date Sep 17, 2014
Website eledon.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$5.00
Upside
+153.81%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ELDN